FR2351658B1 - - Google Patents

Info

Publication number
FR2351658B1
FR2351658B1 FR7714187A FR7714187A FR2351658B1 FR 2351658 B1 FR2351658 B1 FR 2351658B1 FR 7714187 A FR7714187 A FR 7714187A FR 7714187 A FR7714187 A FR 7714187A FR 2351658 B1 FR2351658 B1 FR 2351658B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7714187A
Other versions
FR2351658A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MERCKLE KG CHEM PHARM FABRIK L
Ludwig Merckle GmbH and Co KG Chem Pharm Fabrik
Original Assignee
MERCKLE KG CHEM PHARM FABRIK L
Ludwig Merckle GmbH and Co KG Chem Pharm Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MERCKLE KG CHEM PHARM FABRIK L, Ludwig Merckle GmbH and Co KG Chem Pharm Fabrik filed Critical MERCKLE KG CHEM PHARM FABRIK L
Publication of FR2351658A1 publication Critical patent/FR2351658A1/fr
Application granted granted Critical
Publication of FR2351658B1 publication Critical patent/FR2351658B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7714187A 1976-05-17 1977-05-10 Medicament pour le traitement d'hyperlipoproteinemies primaires et secondaires Granted FR2351658A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762621873 DE2621873C3 (de) 1976-05-17 1976-05-17 Arzneimittel zur Behandlung von Hypercholesterinämien

Publications (2)

Publication Number Publication Date
FR2351658A1 FR2351658A1 (fr) 1977-12-16
FR2351658B1 true FR2351658B1 (fr) 1980-03-14

Family

ID=5978183

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7714187A Granted FR2351658A1 (fr) 1976-05-17 1977-05-10 Medicament pour le traitement d'hyperlipoproteinemies primaires et secondaires

Country Status (3)

Country Link
BE (1) BE854265A (fr)
DE (1) DE2621873C3 (fr)
FR (1) FR2351658A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3411910A1 (de) * 1984-03-30 1985-10-10 Warner-Lambert Co., Morris Plains, N.J. Galenische zubereitung
US9173847B2 (en) 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
CA2540984C (fr) * 2003-10-10 2011-02-08 Lifecycle Pharma A/S Forme de dose solide comprenant un fibrate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792421A (fr) 1971-12-11 1973-06-07 Merck Patent Gmbh Agent pour le traitement des hyperlipoproteinemies et son procede de preparation
DE2411768B2 (de) 1974-03-12 1976-07-01 Adenylchemie Gmbh, 1000 Berlin Arzneimittel mit lipoproteidsenkender wirkung

Also Published As

Publication number Publication date
FR2351658A1 (fr) 1977-12-16
DE2621873C3 (de) 1981-05-07
DE2621873A1 (de) 1977-11-24
DE2621873B2 (de) 1980-08-28
BE854265A (fr) 1977-09-01

Similar Documents

Publication Publication Date Title
CH637799B (fr)
DK140728C (fr)
DE2608011C3 (fr)
DE2749126C3 (fr)
DK141028C (fr)
DE7610659U1 (fr)
CH608555A5 (fr)
CH613774A5 (fr)
BG23485A1 (fr)
CH235076A4 (fr)
CH592988A5 (fr)
CH593347A5 (fr)
CH593478A5 (fr)
CH593485A5 (fr)
CH594137A5 (fr)
CH595610A5 (fr)
CH595819A5 (fr)
CH601738A5 (fr)
CH603378A5 (fr)
CH604351A5 (fr)
CH604441A5 (fr)
CH604445A5 (fr)
CH606749A5 (fr)
CH607969A5 (fr)
CH606475A5 (fr)